Literature DB >> 25432706

IKK-related genetic diseases: probing NF-κB functions in humans and other matters.

Anna Senegas1, Jérémie Gautheron, Alice Gentil Dit Maurin, Gilles Courtois.   

Abstract

The transcription factor NF-κB plays a key role in numerous physiological processes such as inflammation, immunity, cell proliferation or control of cell death. Its activation is tightly controlled by a kinase complex, IκB kinase (IKK), composed of three core proteins: IKK1/IKKα, IKK2/IKKβ and NEMO/IKKγ. The first two are structurally related kinases whereas the third one is a regulatory subunit exhibiting affinity for upstream activators modified by polyubiquitin chains. Over the years, several inherited diseases caused by mutations of each of the three subunits of IKK have been identified in humans together with diseases caused by mutations of several of its substrates. They are associated with very specific and complex phenotypes involving a broad range of abnormalities such as impaired innate and acquired immune response, perturbed skin development and defects of the central nervous system. Here, we summarize the diverse clinical, cellular and molecular manifestations of IKK-related genetic diseases and show that studying patient-related mutations affecting the IKK subunits and some of their substrates offers the opportunity to understand the various functions of NF-κB in humans, complementing studies performed with mouse models. This analysis also provides glimpses about putative functions of IKK subunits that may be NF-κB-independent.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 25432706     DOI: 10.1007/s00018-014-1793-y

Source DB:  PubMed          Journal:  Cell Mol Life Sci        ISSN: 1420-682X            Impact factor:   9.261


  68 in total

Review 1.  Phosphorylation meets ubiquitination: the control of NF-[kappa]B activity.

Authors:  M Karin; Y Ben-Neriah
Journal:  Annu Rev Immunol       Date:  2000       Impact factor: 28.527

2.  A rapid screening method to detect autosomal-dominant ectodermal dysplasia with immune deficiency syndrome.

Authors:  Hidenori Ohnishi; Rie Miyata; Tomonori Suzuki; Touichiro Nose; Kazuo Kubota; Zenichiro Kato; Hideo Kaneko; Naomi Kondo
Journal:  J Allergy Clin Immunol       Date:  2011-11-10       Impact factor: 10.793

3.  The NEMO adaptor bridges the nuclear factor-kappaB and interferon regulatory factor signaling pathways.

Authors:  Tiejun Zhao; Long Yang; Qiang Sun; Meztli Arguello; Dean W Ballard; John Hiscott; Rongtuan Lin
Journal:  Nat Immunol       Date:  2007-04-29       Impact factor: 25.606

4.  Popliteal pterygium syndrome. Evidence for a severe autosomal recessive form.

Authors:  C S Bartsocas; C V Papas
Journal:  J Med Genet       Date:  1972-06       Impact factor: 6.318

5.  Severe liver degeneration in mice lacking the IkappaB kinase 2 gene.

Authors:  Q Li; D Van Antwerp; F Mercurio; K F Lee; I M Verma
Journal:  Science       Date:  1999-04-09       Impact factor: 47.728

6.  Mature T cells depend on signaling through the IKK complex.

Authors:  Marc Schmidt-Supprian; Gilles Courtois; Jane Tian; Anthony J Coyle; Alain Israël; Klaus Rajewsky; Manolis Pasparakis
Journal:  Immunity       Date:  2003-09       Impact factor: 31.745

7.  A novel gain-of-function IKBA mutation underlies ectodermal dysplasia with immunodeficiency and polyendocrinopathy.

Authors:  Lena F Schimke; Nikolaus Rieber; Stacey Rylaarsdam; Otávio Cabral-Marques; Nicholas Hubbard; Anne Puel; Laura Kallmann; Stephanie Anover Sombke; Gundula Notheis; Hans-Peter Schwarz; Birgit Kammer; Tomas Hökfelt; Reinald Repp; Capucine Picard; Jean-Laurent Casanova; Bernd H Belohradsky; Michael H Albert; Hans D Ochs; Ellen D Renner; Troy R Torgerson
Journal:  J Clin Immunol       Date:  2013-05-25       Impact factor: 8.317

8.  Autosomal dominant anhidrotic ectodermal dysplasia with immunodeficiency caused by a novel NFKBIA mutation, p.Ser36Tyr, presents with mild ectodermal dysplasia and non-infectious systemic inflammation.

Authors:  Takakazu Yoshioka; Ryuta Nishikomori; Junichi Hara; Keiko Okada; Yoshiko Hashii; Ikuo Okafuji; Seishiro Nodomi; Tomoki Kawai; Kazushi Izawa; Hidenori Ohnishi; Takahiro Yasumi; Tatsutoshi Nakahata; Toshio Heike
Journal:  J Clin Immunol       Date:  2013-07-18       Impact factor: 8.317

9.  X-linked susceptibility to mycobacteria is caused by mutations in NEMO impairing CD40-dependent IL-12 production.

Authors:  Orchidée Filipe-Santos; Jacinta Bustamante; Margje H Haverkamp; Emilie Vinolo; Cheng-Lung Ku; Anne Puel; David M Frucht; Karin Christel; Horst von Bernuth; Emmanuelle Jouanguy; Jacqueline Feinberg; Anne Durandy; Brigitte Senechal; Ariane Chapgier; Guillaume Vogt; Ludovic de Beaucoudrey; Claire Fieschi; Capucine Picard; Meriem Garfa; Jalel Chemli; Mohamed Bejaoui; Maria N Tsolia; Necil Kutukculer; Alessandro Plebani; Luigi Notarangelo; Christine Bodemer; Frédéric Geissmann; Alain Israël; Michel Véron; Maike Knackstedt; Ridha Barbouche; Laurent Abel; Klaus Magdorf; Dominique Gendrel; Fabrice Agou; Steven M Holland; Jean-Laurent Casanova
Journal:  J Exp Med       Date:  2006-07-03       Impact factor: 14.307

10.  Immunodeficiency and disseminated mycobacterial infection associated with homozygous nonsense mutation of IKKβ.

Authors:  Siobhan O Burns; Vincent Plagnol; Beatriz Morillo Gutierrez; Daifulah Al Zahrani; James Curtis; Miguel Gaspar; Amel Hassan; Alison M Jones; Marian Malone; Dyanne Rampling; Alex McLatchie; Rainer Doffinger; Kimberly C Gilmour; Frances Henriquez; Adrian J Thrasher; H Bobby Gaspar; Sergey Nejentsev
Journal:  J Allergy Clin Immunol       Date:  2014-03-27       Impact factor: 10.793

View more
  15 in total

1.  Succinamide derivatives of melampomagnolide B and their anti-cancer activities.

Authors:  Venumadhav Janganati; Jessica Ponder; Shraddha Thakkar; Craig T Jordan; Peter A Crooks
Journal:  Bioorg Med Chem       Date:  2017-05-08       Impact factor: 3.641

2.  Topical Application of a Dual ABC Transporter Substrate and NF-κB Inhibitor Blocks Multiple Sources of Cutaneous Inflammation in Mouse Skin.

Authors:  Luowei Li; Christophe Cataisson; Brittany Flowers; Elise Fraser; Vanesa Sanchez; Chi-Ping Day; Stuart H Yuspa
Journal:  J Invest Dermatol       Date:  2019-01-23       Impact factor: 8.551

3.  A Central Region of NF-κB Essential Modulator Is Required for IKKβ-Induced Conformational Change and for Signal Propagation.

Authors:  Robert Shaffer; Anthony M DeMaria; Larisa Kagermazova; Yuekun Liu; Milad Babaei; Suhaily Caban-Penix; Arisdelsy Cervantes; Stefan Jehle; Lee Makowski; Thomas D Gilmore; Adrian Whitty; Karen N Allen
Journal:  Biochemistry       Date:  2019-06-18       Impact factor: 3.321

4.  BK virus encephalopathy and sclerosing vasculopathy in a patient with hypohidrotic ectodermal dysplasia and immunodeficiency.

Authors:  Armine Darbinyan; Eugene O Major; Susan Morgello; Steven Holland; Caroline Ryschkewitsch; Maria Chiara Monaco; Thomas P Naidich; Joshua Bederson; Joanna Malaczynska; Fei Ye; Ronald Gordon; Charlotte Cunningham-Rundles; Mary Fowkes; Nadejda M Tsankova
Journal:  Acta Neuropathol Commun       Date:  2016-07-13       Impact factor: 7.801

5.  Mutation of cysteine 46 in IKK-beta increases inflammatory responses.

Authors:  Ting Li; Vincent Kam Wai Wong; Zhi Hong Jiang; Shui Ping Jiang; Yan Liu; Ting Yu Wang; Xiao Jun Yao; Xiao Hui Su; Feng Gen Yan; Juan Liu; Elaine Lai-Han Leung; Xiao Qin Yi; Yuen Fan Wong; Hua Zhou; Liang Liu
Journal:  Oncotarget       Date:  2015-10-13

6.  Ikk2 regulates cytokinesis during vertebrate development.

Authors:  Hongyuan Shen; Eun Myoung Shin; Serene Lee; Sinnakaruppan Mathavan; Hiromi Koh; Motomi Osato; Hyungwon Choi; Vinay Tergaonkar; Vladimir Korzh
Journal:  Sci Rep       Date:  2017-08-14       Impact factor: 4.379

Review 7.  NF-κB in Hematological Malignancies.

Authors:  Véronique Imbert; Jean-François Peyron
Journal:  Biomedicines       Date:  2017-05-31

Review 8.  The BCR-ABL/NF-κB signal transduction network: a long lasting relationship in Philadelphia positive Leukemias.

Authors:  Giovanna Carrà; Davide Torti; Sabrina Crivellaro; Cristina Panuzzo; Riccardo Taulli; Daniela Cilloni; Angelo Guerrasio; Giuseppe Saglio; Alessandro Morotti
Journal:  Oncotarget       Date:  2016-10-04

9.  Interactome analysis of transforming growth factor-β-activated kinase 1 in Helicobacter pylori-infected cells revealed novel regulators tripartite motif 28 and CDC37.

Authors:  Olga Sokolova; Thilo Kähne; Kenneth Bryan; Michael Naumann
Journal:  Oncotarget       Date:  2018-02-21

10.  Receptor-interacting protein kinase 1 (RIPK1) as a therapeutic target.

Authors:  Lauren Mifflin; Dimitry Ofengeim; Junying Yuan
Journal:  Nat Rev Drug Discov       Date:  2020-07-15       Impact factor: 112.288

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.